Generation of an induced pluripotent stem cell line (HMSCATi004-A) from an early onset Parkinson's disease patient with PRKN gene mutation

被引:0
|
作者
Cheng, Jingke [1 ,2 ]
Zhai, Yingtong [1 ,2 ]
Guo, Xiangge [1 ,2 ]
Wang, Xumeng [1 ,2 ]
Ma, Min [1 ,6 ]
Ren, Xin [5 ]
Wang, Shan [5 ]
Cui, Huixian [1 ,2 ,3 ]
Ren, Qian [1 ,2 ,3 ,4 ]
机构
[1] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Int Cooperat Lab Stem Cell Res, Shijiazhuang, Peoples R China
[3] Hebei Med Univ, Hebei Key Lab Neurodegenerat Dis Mech, Shijiazhuang, Peoples R China
[4] Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang, Peoples R China
[5] Hebei Med Univ, Dept Neurol, Hosp 2, Shijiazhuang, Peoples R China
[6] Hebei Med Univ, Human Brain Bank, Shijiazhuang, Peoples R China
关键词
D O I
10.1016/j.scr.2024.103578
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Parkin (PRKN) is recognized as causative gene in early-onset Parkinson's disease (PD). Induced pluripotent stem cells (iPSCs) were derived from a 29-year-old PD patient carrying a heterozygous c.823C > T (p.R275W) variant and an exon 2-4 deletion in PRKN. The Generated iPSCs maintain a normal karyotype, express pluripotency markers, and retain the ability to differentiate into the three germ layers. This iPSC line serves as a valuable cellular model for investigating the pathogenesis of early-onset PD and development of potential therapeutic interventions.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation
    Chen, Muwan
    Maimaitili, Muyesier
    Buchholdta, Susanne Hvolbol
    Jensen, Uffe Birk
    Febbraro, Fabia
    Denham, Mark
    STEM CELL RESEARCH, 2020, 45
  • [22] Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease
    Marote, Ana
    Pomeshchik, Yuriy
    Goldwurm, Stefano
    Collin, Anna
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 82 - 85
  • [23] Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient
    Ma, Jun
    Guo, Ruiyun
    Song, Yongzhou
    Zhang, Jing
    Feng, Baofeng
    Amponsah, Asiamah Ernest
    Kong, Desheng
    He, Jingjing
    Zhang, Wei
    Liu, Aijing
    Wei, Lin
    Shen, Sanbing
    O'Brien, Timothy
    Cui, Huixian
    STEM CELL RESEARCH, 2019, 36
  • [24] Generation of a human induced pluripotent stem cell line from a female patient carrying LZTR1 gene mutation
    Ruan, Jinghua
    Wu, Mengqing
    Xiang, Jiakai
    Hui, Xianrui
    Yang, Lijun
    Lin, Ru
    Xu, Weize
    Shu, Qiang
    STEM CELL RESEARCH, 2024, 81
  • [25] Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
    Grigor'eva, Elena, V
    Drozdova, Elena S.
    Sorogina, Diana A.
    Malakhova, Anastasia A.
    Pavlova, Sofia, V
    Vyatkin, Yuri V.
    Khabarova, Elena A.
    Rzaev, Jamil A.
    Medvedev, Sergey P.
    Zakian, Suren M.
    STEM CELL RESEARCH, 2022, 59
  • [26] Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer's disease
    Wang, Zhuoya
    Sun, Huifang
    Zhang, Qi
    Yang, Jing
    Liu, Yutao
    Liu, Han
    Shi, Changhe
    Wang, Yanlin
    Xu, Yuming
    STEM CELL RESEARCH, 2021, 53
  • [27] Generation ofan induced pluripotent stem cell line (EURACi014-A) from a Parkinson's disease patient with an A53T mutation in the SNCA gene by an integration-free reprogramming method
    Gilmozzi, Valentina
    Gentile, Giovanna
    Riekschnitz, Diana A.
    Volpato, Claudia B.
    Di Segni, Marina
    Silipigni, Rosamaria P.
    Pramstaller, Peter P. A.
    Hicks, Andrew A.
    Pichler, Irene
    Zanon, Alessandra
    STEM CELL RESEARCH, 2022, 60
  • [28] Generation of induced pluripotent stem cell line from a patient with long COVID
    Wu, David
    Manhas, Amit
    Noishiki, Chikage
    Tripathi, Dipti
    Liu, Lu
    Turbes, Naima
    Thomas, Dilip
    Sallam, Karim
    Lee, Jason T.
    Sayed, Nazish
    STEM CELL RESEARCH, 2025, 83
  • [29] Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene
    Zhang, Qinxian
    Li, Zhuo
    Sun, Huifang
    Zhang, Shoutao
    Zhang, Jin
    Wang, Yanlin
    Fang, Hui
    Xu, Yuming
    STEM CELL RESEARCH, 2019, 35
  • [30] Generation of induced pluripotent stem cell line (XWHNi003-A) from a female with APOE gene mutation
    Gong, Jin
    Li, Shaoqi
    Sun, Wenxian
    Wang, Pin
    Han, Xiaodong
    Xu, Chang
    Chen, Yufei
    Yang, Yuting
    Luan, Heya
    Li, Ruina
    Wen, Boye
    Lv, Sirong
    Chen, Runqi
    Guo, Jinxuan
    Wei, Cuibai
    STEM CELL RESEARCH, 2024, 79